Stocks
BridgeBio (BBIO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -765.7% | -511.9% | -6 078% | -196.9% | -134.0% | -103.6% | ||
| Changes by years, y/y, % | +4 900pp | +254pp | -5 566pp | +5 881pp | +63pp | -52.7% | |||
BridgeBio. EBITDA margin, %
BridgeBio. EBITDA margin, changes, pp
BridgeBio (BBIO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -108.2% | -129.1% | -143.6% | -116.9% | -57.9% | -103.6% | |
| Changes by years, y/y, % | -103pp | +2 225pp | +4 968pp | +3 879pp | +50pp | |||
| Changes by quarters, q/q, % | +3 888pp | -21pp | -15pp | +27pp | +59pp | |||
